A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 1, 2002, Pages 104-105

  Hulse, G K ^a   O'Neill, G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; NALTREXONE; POLYLACTIDE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DRUG DETOXIFICATION; DRUG IMPLANT; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; FETUS MONITORING; HEROIN DEPENDENCE; HIGH RISK PREGNANCY; HUMAN; NATURAL CHILDBIRTH; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE;

EID: 0036177364     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.00104.x     Document Type: Article

References (2)

1. The association between naltrexone compliance and daily supervision
2. Obstetric and neonatal outcomes associated with maternal naltrexone exposure